Jing Zhan Selected Research

Jing Zhan Research Topics

Disease

10	Neoplasms (Cancer) 08/2023 - 03/2011
5	Obesity 06/2022 - 01/2019
4	Body Weight (Weight, Body) 01/2022 - 02/2018
3	Wounds and Injuries (Trauma) 04/2024 - 05/2015
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2019
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2015 - 08/2003
2	Inflammation (Inflammations) 04/2024 - 11/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 04/2020
2	Thyroid Neoplasms (Thyroid Cancer) 12/2023 - 03/2011
2	Infections 10/2022 - 11/2021
2	Neoplasm Metastasis (Metastasis) 05/2022 - 05/2018
2	Neutropenia 03/2021 - 02/2013
2	Leukopenia 03/2021 - 03/2012
2	Dysbiosis 11/2020 - 04/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020 - 03/2011
2	Insulin Resistance 11/2019 - 01/2019
1	Tissue Adhesions 04/2024
1	Foreign Bodies (Foreign Body) 04/2024
1	Hypersensitivity (Allergy) 02/2024
1	Congenital Abnormalities (Deformity) 01/2024
1	Chronic Renal Insufficiency 11/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2023
1	Lymphoma (Lymphomas) 10/2023
1	Hemolysis 06/2023
1	Thrombosis (Thrombus) 06/2023
1	Breast Neoplasms (Breast Cancer) 06/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Burns 12/2022
1	Surgical Wound 07/2022
1	Pain (Aches) 07/2022
1	Hypoxia (Hypoxemia) 05/2022
1	Nasopharyngeal Carcinoma 03/2021
1	Febrile Neutropenia 03/2021
1	Hypertrophy 11/2020
1	Overweight 11/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Diarrhea 01/2020
1	Weight Gain 01/2019

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2023 - 08/2023
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 03/2011
2	vandetanib (ZD6474)IBA 05/2022 - 03/2011
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2022 - 03/2011
2	LipopolysaccharidesIBA 01/2022 - 11/2019
2	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 04/2020
2	Dichlorodiphenyl Dichloroethylene (DDE)IBA 04/2020 - 01/2019
2	LipidsIBA 04/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 02/2006
2	puquitinibIBA 10/2018 - 12/2015
1	Biocompatible Materials (Biomaterials)IBA 04/2024
1	DEET (DET)IBA 04/2024
1	SpermidineIBA 04/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	HydrogelsIBA 04/2024
1	Immunoglobulin G (IgG)IBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	Immunoglobulin M (IgM)IBA 02/2024
1	Immunoglobulin A (IgA)IBA 02/2024
1	Hemolysin Proteins (Hemolysins)IBA 02/2024
1	Polysorbates (PSML)FDA Link 01/2024
1	ferric derisomaltoseIBA 01/2024
1	Polystyrenes (Polystyrene)IBA 11/2023
1	Complement System Proteins (Complement)IBA 11/2023
1	MicroplasticsIBA 11/2023
1	Uremic ToxinsIBA 10/2023
1	Silicon Dioxide (Silica)FDA LinkGeneric 06/2023
1	PhosphatidylserinesIBA 06/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Cancer VaccinesIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Oxygen (Dioxygen)IBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	CytokinesIBA 10/2022
1	Bile Acids and Salts (Bile Acids)IBA 06/2022
1	Volatile Fatty AcidsIBA 06/2022
1	Transcription Factors (Transcription Factor)IBA 05/2022
1	Tyrosine Kinase InhibitorsIBA 05/2022
1	Docetaxel (Taxotere)FDA Link 03/2021
1	Insulin (Novolin)FDA Link 11/2020
1	tributyltinIBA 11/2020
1	Gefitinib (Iressa)FDA Link 06/2020
1	apatinibIBA 06/2020
1	Persistent Organic PollutantsIBA 04/2020
1	VaccinesIBA 01/2020
1	Chlorpyrifos (Lorsban)IBA 11/2019
1	PesticidesIBA 11/2019
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	Dietary Fiber FDA Link 01/2019
1	PectinsIBA 01/2019
1	Transcription Factor 4IBA 01/2019

Therapy/Procedure

7	Therapeutics 06/2023 - 03/2011
3	Drug Therapy (Chemotherapy) 03/2021 - 08/2003
1	Injections 04/2024
1	Manual Lymphatic Drainage 06/2023
1	Modified Radical Mastectomy (Mastectomy, Modified) 06/2023
1	Immunotherapy 01/2023
1	Aftercare (After-Treatment) 07/2022
1	Operative Time 07/2022
1	Fecal Microbiota Transplantation 11/2020